Literature DB >> 10369555

Neuroprotective effects of basic fibroblast growth factor following spinal cord contusion injury in the rat.

T T Lee1, B A Green, W D Dietrich, R P Yezierski.   

Abstract

Cytokines and neurotrophic factors have been implicated in the pathophysiology of injury to the central nervous system. While some cytokines are considered pro-inflammatory, other factors promote neuronal growth and survival. The present study investigated the neuroprotective effects of interleukins 1 (IL-1), 4 (IL-4), and 6 (IL-6), nerve growth factor (NGF), ciliary neurotrophic factor (CNTF), and basic fibroblast growth factor (bFGF) in a contusion model of spinal cord injury. Female Sprague-Dawley rats (n = 55) sustained a 10-g weight-drop injury to the lower thoracic spinal cord (T10) from a height of 12.5 mm using the NYU impactor. A micro-infusion system (Alzet minipump) was used to continuously deliver drugs or vehicle directly into the epicenter of the contused spinal cord starting 1 or three h postinjury. At the end of 7 days, animals were perfused and the cords removed for histopathological analysis. Longitudinal serial sections were cut on a freezing microtome and stained with cresyl violet. Areas of central necrosis, partial preservation, and total zone of tissue injury were identified and traced by an independent reviewer using a computer based imaging system. The mean total zone of injury in five animals receiving vehicle infusion was 18.04+/-4.20 mm3. The mean zone of partial preservation in these animals was 16.46+/-3.32 mm. Basic fibroblast growth factor reduced the total zone of injury by 33% [p<0.01, least significant difference (LSD) of Fisher] in five animals and the zone of partial preservation by 32% (p<0.01, LSD of Fisher) when compared to controls. There were trends toward reduction in total zone of injury and zone of partial preservation in rats treated with IL-4, CNTF, and NGF versus vehicle; however, none of these reached statistical significance. No significant differences were observed between animals receiving vehicle versus bFGF treatment commencing 3 h after injury. These data demonstrate that the continuous intramedullary infusion of bFGF initiated one hour after moderate contusion injury of the spinal cord significantly reduces the total zone of injury and the zone of partial preservation. These results support the further investigation and possible future clinical application of bFGF in the treatment of acute spinal cord contusion injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369555     DOI: 10.1089/neu.1999.16.347

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  18 in total

1.  Proof-of Concept that an Acute Trophic Factors Intervention After Spinal Cord Injury Provides an Adequate Niche for Neuroprotection, Recruitment of Nestin-Expressing Progenitors and Regeneration.

Authors:  Warin Krityakiarana; Paul M Zhao; Kevin Nguyen; Fernando Gomez-Pinilla; Naiphinich Kotchabhakdi; Jean de Vellis; Araceli Espinosa-Jeffrey
Journal:  Neurochem Res       Date:  2016-02-17       Impact factor: 3.996

2.  Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord.

Authors:  Kristina A Kigerl; John C Gensel; Daniel P Ankeny; Jessica K Alexander; Dustin J Donnelly; Phillip G Popovich
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

3.  Comparative analysis between thoracic spinal cord and sacral neuromodulation in a rat spinal cord injury model: a preliminary report of a rat spinal cord stimulation model.

Authors:  Seung-Jae Hyun; Chang-Hyun Lee; Ji Woong Kwon; Cheol-Yong Yoon; Jae-Young Lim; Ki-Jeong Kim; Tae-Ahn Jahng; Hyun-Jib Kim
Journal:  Korean J Spine       Date:  2013-03-31

4.  Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway.

Authors:  Ru-Rong Ji; Yasuhiko Kawasaki; Zhi-Ye Zhuang; Yeong-Ray Wen; Isabelle Decosterd
Journal:  Neuron Glia Biol       Date:  2006-11

5.  Fabrication of growth factor- and extracellular matrix-loaded, gelatin-based scaffolds and their biocompatibility with Schwann cells and dorsal root ganglia.

Authors:  Rodolfo E Gámez Sazo; Katsumi Maenaka; Weiyong Gu; Patrick M Wood; Mary Bartlett Bunge
Journal:  Biomaterials       Date:  2012-08-17       Impact factor: 12.479

6.  Fgf-2 in astroglial cells during vertebrate spinal cord recovery.

Authors:  Gehan H Fahmy; Marie Z Moftah
Journal:  Front Cell Neurosci       Date:  2010-11-04       Impact factor: 5.505

7.  Neuroprotective effects of sacral epidural neuromodulation following spinal cord injury : an experimental study in rats.

Authors:  Chang-Hyun Lee; Seung-Jae Hyun; Cheol-Yong Yoon; Jae-Young Lim; Tae-Ahn Jahng; Ki-Jeong Kim
Journal:  J Korean Neurosurg Soc       Date:  2012-12-31

8.  Fgf2 improves functional recovery-decreasing gliosis and increasing radial glia and neural progenitor cells after spinal cord injury.

Authors:  Yona Goldshmit; Frisca Frisca; Alexander R Pinto; Alice Pébay; Jean-Kitty K Y Tang; Ashley L Siegel; Jan Kaslin; Peter D Currie
Journal:  Brain Behav       Date:  2014-01-13       Impact factor: 2.708

9.  The potential for cellular therapy combined with growth factors in spinal cord injury.

Authors:  Jack Rosner; Pablo Avalos; Frank Acosta; John Liu; Doniel Drazin
Journal:  Stem Cells Int       Date:  2012-10-03       Impact factor: 5.443

10.  Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord.

Authors:  Chang-Ching Yang; Yang-Hsin Shih; Miau-Hwa Ko; Shao-Yun Hsu; Henrich Cheng; Yu-Show Fu
Journal:  PLoS One       Date:  2008-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.